Description
This webinar offers healthcare professionals an in-depth review of TB treatment fundamentals. Learners will explore the historical context of therapy, current standard six-month HRZE regimens, and newer four-month rifapentine-moxifloxacin options. The session covers drug mechanisms, dosing protocols, monitoring strategies, and management of common adverse effects such as hepatotoxicity, gastrointestinal issues, and rash. Guidance on handling treatment interruptions, recognizing treatment failure, and managing extrapulmonary TB is also included.
Target Audience
This presentation is designed for rapid-response situations where healthcare teams need quick, essential TB information. It is designed for allied health professionals, nurses, physicians, physician assistants, residents, and other staff in public health or clinical settings.
Learning Objectives
- Explain standard and newer TB treatment regimens
- Identify key dosing, monitoring steps, and common side effects
- Apply strategies for treatment interruptions and extrapulmonary TB